Please Wait

Applying Filters...

Find excipient solutions to address Choline, hydroxide, succinate (2:1), dihydrochloride formulation challenges (e.g. drug delivery, bioavailability, taste masking, controlled release, solubility, stability etc).

Choline, hydroxide, succinate (2:1), dihydrochloride

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

26 API Suppliers, 10 USDMF, 3 CEP/COS, 1 JDMF, 6 EU WC, 7 NDC API, 13 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

4 Drugs in Development

4 Drugs in Development

FINISHED DOSAGE FORMULATIONS

63 FDF Dossiers, 40 FDA Orange Book, 4 Europe, 3 Canada, 2 South Africa, 14 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INJECTION - 20MG/ML, INJECTABLE;INJECTION - 100MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - 20MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - 50MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

3 Actylis

3 Actylis

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 58 News #PharmaBuzz

GLOBAL SALES INFORMATION

3 Regulatory FDF Prices

3 Regulatory FDF Prices

MARKET PLACE

18 APIs, 9 FDF Dossiers

PATENTS & EXCLUSIVITIES

1 US Patents

1 US Patents

REF. STANDARDS & IMPURITIES

1 EDQM

1 EDQM

$ Xls

Filters

Choline, Hydroxide, Succinate (2:1), Dihydrochloride

Filters

FILTER :

filter Company Reset all filters

3 All

01 3Actylis

filter Capability Reset all filters

filter Country Reset all filters

01

Actylis

HYDROCHLORIC ACID NF

AGGSpend

Not Confirmed

02

Actylis

SODIUM CHLORIDE USP

AGGSpend

Not Confirmed

03

Actylis

NACL MULTI-COMPENDIAL LOW ENDOTOXIN

AGGSpend

Not Confirmed